Estimating willingness to pay for the Covid-19 vaccine using the conditional valuation method

Adeli, Omid Ali; kashi, Sanaz Rahimi kah

doi:10.52547/payesh.20.2.223

Cited by 6 publications

(9 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Signi cant differences in willingness to pay (WTP) for vaccines were observed across different levels of vaccine attitudes, indicating that respondents' attitudes, knowledge, and awareness were important factors in determining WTP. These ndings are consistent with previous studies by Nam Juan et al (2021) andAdeli et al (2021)…”

supporting

confidence: 94%

“…The study found that participants were willing to pay an average of $ (9,11). The study examined several vaccines, including domestic, AstraZeneca, Sinopharm, and Sputnik, and found that gender did not have a signi cant effect on willingness to pay (WTP).…”

Section: Discussionmentioning

confidence: 99%

“…Other studies, such as Adeli (2021), a higher average WTP of $8.92 (equivalent to 375,000 tomans), while Harapan et al (2020) found an average WTP of $58 per person. Parents in Katma et al's (2021) study were willing to pay up to $291 for their own vaccine and $243 to $321 for their children's, while immigrants in Han Kai et al's (2021) study were willing to pay an average of $46 for vaccine(4,9,12, 18). The results suggest that other countries have higher market values for vaccination, possibly due to exchange rates and higher per capita income.In all the vaccine brands examined in this study, no signi cant difference was found in the WTP at different ages.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Estimation of The Value of COVID-19 Vaccine in General Public in South- east of Iran: A Willingness to pay Study

Najafi,

Goudarzi,

Feyzabadi

2023

Preprint

View full text Add to dashboard Cite

Background: The COVID-19 virus is a recent global phenomenon that emerged in 2019, and its impact has affected the lives of billions of people in various ways. Since the government provides vaccination for free, it is necessary to perform an economic valuation through willingness-to-pay analysis to determine its value in monetary terms. This study aims to estimate the amount that the general public of Kerman city is willing to pay for COVID-19 vaccine. Methods: This is a cross-sectional survey study conducted in September 2022 using face-to-face interviews with the general public of Kerman city, located in the southeastern region of Iran. Cochran's formula was used to determine the sample size of 500 households, selected through the Multistage sampling method. An open-ended question approach was employed to estimate the willingness of individuals to pay for the COVID-19 vaccine. The main questionnaire of the study consisted of three parts. Quantification tests were conducted to check for normality and variance heterogeneity, and the Kolmogorov-Smirnov test was used to verify the normality of the data. Stata 17 software was used for data analysis. Results: The open-ended question results of the respondents' willingness to pay for the COVID-19 vaccine showed that the highest average stated was for the AstraZeneca vaccine ($9.73), while the lowest average reported was for the domestically produced vaccine ($5.74). Factors affecting the willingness to pay were examined, and it was found that variables such as employment status, education level, attitude towards vaccination, income, and number of vaccine doses significantly influenced the willingness to pay. Conclusion: Based on the findings of this study, as low-income individuals and those with lower levels of education reported a lower willingness to pay, it is recommended that the government provide free vaccination to low-income groups and focus on building trust and promoting vaccine culture among those with lower education levels. Additionally, measures can be taken to enable high-income individuals to obtain the vaccine through the private sector.

show abstract

supporting

confidence: 94%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Estimation of The Value of COVID-19 Vaccine in General Public in South- east of Iran: A Willingness to pay Study

Najafi,

Goudarzi,

Feyzabadi

2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Therefore, identifying the determinants associated with the WTP for the COVID-19 vaccine is essential for the government and other organizations to design an excellent intervention to be used in key populations [6][7][8][9]. Studies have evaluated the acceptance and the WTP for the COVID-19 vaccine globally but in Iran such evidence is limited [10,11].…”

Section: Introductionmentioning

confidence: 99%

Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment

Darrudi

Daroudi

Yunesian

et al. 2022

PharmacoEconomics Open

View full text Add to dashboard Cite

Background and objective The coronavirus disease 2019 (COVID-19) pandemic is a major international threat and vaccination is the most robust strategy to terminate this crisis. It is helpful for policymakers to be aware of community preferences about vaccines. The present study aims to investigate the public’s preferences and willingness to pay for the COVID-19 vaccine in Iran. Methods This research is a cross-sectional study performed using a discrete choice experiment for a sample of the public population of several provinces of Iran in 2021. The samples were divided into two groups: one group expressed their preferences regarding the vaccine’s attributes, and another group expressed their preferences regarding prioritizing individuals to get the vaccine. The discrete choice experiment design included five attributes including effectiveness, risk of severe complications, price, location of vaccine production, and duration of protection related to preferences for vaccine selection and six attributes including age, underlying diseases, employment in the healthcare sector, the rate of virus spread, the necessary job, and cost to the community related to preferences for prioritizing individuals to get the vaccine. A total of 715 individuals completed the questionnaire. The conditional logit regression model was used to analyze the discrete choice experiment data. Willingness to pay for each attribute was also calculated. Results The willingness to pay for the COVID-19 vaccine with 90% (70%) efficacy, the risk of severe complications for 1 (5) person per one million people, imported (domestic) vaccine, and 24-month (12-month) duration of protection attributes was about US$71 (US$37). The preference for vaccination for respondents was enhanced by increasing the efficacy and the duration of vaccine protection and decreasing complications and costs. The likelihood of prioritizing individuals to get a vaccination was increased for a person with an underlying disease, employment in the healthcare sector, the necessary job for the community, the high potential for virus spread in the community, and the high cost of death to the community. The age variable was not statistically significant for prioritizing individuals to get the vaccine. Conclusions In the setting of the COVID-19 vaccination program, the public’s preferences identified in this study should be considered. The obtained results provide useful information for policymakers to identify individual and social values for an appropriate vaccination strategy. Supplementary Information The online version contains supplementary material available at 10.1007/s41669-022-00359-x.

show abstract

“…While the Iran Ministry of Health has initiated a vaccine dissemination process among HCWs to control the pandemic, surveys show that many of these employees are unwilling to receive their vaccine. [ 9 ] Therefore, it is extremely important to understand the intentions, motivations, and barriers affecting HCWs decision to get vaccinated against COVID-19. This knowledge can help policymakers to develop effective interventional programs to increase COVID-19 vaccination acceptance among HCWs.…”

Section: Introductionmentioning

confidence: 99%

Intention to get Vaccinated Against COVID-19 in Iranian Hospital Staff

Bashirian

Shirahmadi

Khazaei³

et al. 2022

Indian Journal of Occupational and Environmental Medicine

View full text Add to dashboard Cite

Background: This study aimed to identify the predictors of the intention to receive the COVID-19 vaccine among Iranian health care workers (HCWs) based on the Theory of Planned Behavior (TPB). Methods: The study was a descriptive cross-sectional study that was conducted on 473 personnel working in hospitals of Hamadan, in May 2021 and before COVID-19 vaccination on hospital staff. The multi-stage sampling method was used for choosing participants. The survey included socio-demographic, questions related to TPB dimensions, and intention to receive a COVID-19 vaccine. Qualitative and quantitative data analyses were performed using the Chi-square test and T-test, respectively. Predictors of COVID-19 vaccination intention were determined using the logistic regression model. Results: Seventy percent of 361 eligible respondents stated their willingness to receive COVID-19 vaccine. The participants with the intention to receive COVID-19 vaccine had higher scores of attitude (7.25 ± 3.92 vs. 4.40 ± 5.14) and norm (3.04 ± 2.92 vs. -0.5 ± 3.18) ( P < 0.001). Having an underlying disease and being married were significantly associated with the intention to receive COVID-19 vaccine ( P < 0.05). Higher attitude and norm scores as a construct of the TPB were associated with an increase in intention to receive COVID-19 vaccine. Conclusions: The results of this study showed that the vaccination intention was affected by social, demographic, health, and behavioral features, such as age, marital status, underlying diseases, subjective norms, and attitude. Therefore, age groups below 50, single people, and those with no underlying diseases were eligible to be the target of interventional programs.

show abstract

Estimating willingness to pay for the Covid-19 vaccine using the conditional valuation method

Cited by 6 publications

References 5 publications

Estimation of The Value of COVID-19 Vaccine in General Public in South- east of Iran: A Willingness to pay Study

Estimation of The Value of COVID-19 Vaccine in General Public in South- east of Iran: A Willingness to pay Study

Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment

Intention to get Vaccinated Against COVID-19 in Iranian Hospital Staff

Contact Info

Product

Resources

About